Voice AI Startup Assort Health Secures $102M in Funding to Revolutionize Healthcare Call Centers

Assort Health, a cutting-edge voice AI startup, has successfully raised $76 million in a Series B funding round, bringing its total funding to an impressive $102 million in just four months. The company, which specializes in automating healthcare call centers with specialty-specific voice AI agents, is poised to transform patient engagement and streamline healthcare operations.

Groundbreaking AI Technology for Healthcare Communication

Assort Health's innovative platform, AssortOS, integrates seamlessly with providers' electronic health records and practice management software. The AI-powered system can handle a wide range of tasks, including:

• Triaging incoming patient calls
• Answering frequently asked questions
• Routing patients to appropriate clinic personnel
• Scheduling appointments
• Resolving patient issues efficiently

The company's AI agents cover various medical specialties, from orthopedics to cardiology and immunology, offering a comprehensive solution for healthcare providers.

Rapid Growth and Industry Recognition

The Series B funding round was led by Lightspeed Venture Partners, with participation from notable investors such as Felicis, First Round Capital, Chemistry, A*, Liquid2, and Quiet Capital. This follows closely on the heels of Assort Health's Series A round in April, which was co-led by First Round Capital and Chemistry.

As part of the funding agreement, Galym Imanbayev, M.D., partner at Lightspeed Venture Partners, will join Assort Health's board. Additionally, Paul Ricci, founding CEO of Nuance, has been appointed as a board advisor, bringing valuable industry expertise to the company.

Expanding Capabilities and Market Presence

Assort Health plans to utilize the newly acquired funds to grow its team and further develop the AssortOS platform. The company's co-CEO and co-founder, Jon Wang, emphasized the rapid return on investment for customers, stating that they typically see ROI in approximately 30 days.

Jeffery Liu, founder and co-CEO, highlighted the superiority of Assort Health's technology over traditional voice AI solutions. He explained, "Most 'voice AI' is a prompt thrown into a voice pipeline. It's slow to implement, shallow in coverage and prone to unsafe hallucinations. Assort Intelligence delivers end-to-end automation across scheduling, triage and patient comms with industry leading workflow coverage, patient safety and performance guardrails."

The company's capabilities extend beyond basic call center functions, encompassing care navigation, lab test management, prescription renewals, and physician referrals. This comprehensive approach to healthcare workflow automation positions Assort Health as a leader in the emerging AI-native era of patient engagement.